Medifast (NYSE:MED) Stock Crosses Above 200 Day Moving Average - Should You Sell?

Medifast Inc (NYSE:MED - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $14.33 and traded as high as $14.75. Medifast shares last traded at $14.58, with a volume of 104,789 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised shares of Medifast from a "hold" rating to a "buy" rating in a research note on Thursday, May 1st.

Medifast Stock Down 0.3%

The company has a market capitalization of $160.23 million, a PE ratio of -22.43 and a beta of 0.86. The firm's 50-day moving average is $13.47 and its 200-day moving average is $14.33.

Medifast (NYSE:MED - Get Free Report) last posted its quarterly earnings data on Monday, April 28th. The specialty retailer reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.07) by ($0.04). The firm had revenue of $115.73 million during the quarter, compared to analysts' expectations of $114.85 million. Medifast had a positive return on equity of 6.63% and a negative net margin of 1.29%. As a group, equities research analysts predict that Medifast Inc will post 0.51 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Northern Trust Corp grew its stake in shares of Medifast by 0.9% during the fourth quarter. Northern Trust Corp now owns 101,775 shares of the specialty retailer's stock valued at $1,793,000 after buying an additional 871 shares during the last quarter. SummerHaven Investment Management LLC grew its position in Medifast by 2.2% during the 1st quarter. SummerHaven Investment Management LLC now owns 42,073 shares of the specialty retailer's stock worth $567,000 after acquiring an additional 916 shares during the last quarter. Wells Fargo & Company MN grew its position in Medifast by 23.5% during the 4th quarter. Wells Fargo & Company MN now owns 6,459 shares of the specialty retailer's stock worth $114,000 after acquiring an additional 1,227 shares during the last quarter. Geode Capital Management LLC increased its stake in Medifast by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 245,929 shares of the specialty retailer's stock worth $4,335,000 after purchasing an additional 1,447 shares during the period. Finally, Barclays PLC lifted its position in Medifast by 15.1% in the fourth quarter. Barclays PLC now owns 16,194 shares of the specialty retailer's stock valued at $285,000 after purchasing an additional 2,127 shares during the last quarter. 95.51% of the stock is currently owned by institutional investors.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.